Status: Not yet recruiting
Vortioxetine for Depressive Symptoms and Freezing of Gait in Parkinson Disease
The present study involves patients with Parkinson Disease (PD) suffering from freezing of gait (FOG) and depressive symptoms. The main aim of the study is evaluating the efficacy of vortioxetine in reducing moderate/severe FOG not responsive to dopaminergic treatment in patients with PD with depressive symptoms.
Participants needed: 40
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Marianna AmboniUpdated: Feb 6, 2025
Eligibility criteria
Diagnosis of PD according to published criteria [+3]
Treatment with IMAO-B (rasagiline, selegiline, safinamide) (to be included, IMAO... [+5]